Patent · US Active

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

US8747833B2 · kind B2 · utility

15Cited by
106References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 24, 2011
Grant dateJun 10, 2014
Priority date
Expiry dateJan 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features methods of diagnosis by assessing B7-H1 expression in a tissue from a subject that has, or is suspected of having, cancer, methods of treatment with agents that interfere with B7-H1-receptor interaction, methods of selecting candidate subjects likely to benefit from cancer immunotherapy, and methods of inhibiting expression of B7-H1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.